García-Bujalance S, Ruiz G, De Guevara C Ladrón, Peña J M, Bates I, Vázquez J J, Gutiérrez A
Department of Microbiology and Parasitology, Facultad de Medicina, La Paz University Hospital, Universidad Autónoma Madrid, Paseo de la Castellana 261, 28046 Madrid, Spain.
Eur J Clin Microbiol Infect Dis. 2004 Feb;23(2):111-5. doi: 10.1007/s10096-003-1058-4. Epub 2004 Jan 20.
The purpose of this study was to analyze the quantitation of the human immunodeficiency virus type 1 RNA (HIV-1 RNA) in the genital tract of HIV-1-infected pregnant women and to evaluate a possible correlation with the viral load in blood plasma (Spearman's rank correlation coefficient). A total of 38 each of cervical, vaginal, and blood samples from 38 women were obtained during the third trimester of pregnancy for quantitation of the HIV-1 RNA load. Viral loads were determined by reverse transcription-polymerase chain reaction. The HIV-1 RNA viral load was detectable in 29 of the 38 (76.3%) blood samples, in 6 of the 38 (15.7%) cervical secretion samples, and in 8 of the 38 (21%) vaginal secretion samples. Overall, the correlation between the HIV-1 RNA viral load in the blood plasma and in cervical secretion samples was 0.51 ( P<0.001). However, the correlation disappeared ( r=0.27) when three patients with high blood plasma viral loads were eliminated from the statistical study. The viral load in the vaginal secretions did not correlate with that in the blood samples ( r=0.26). There were two cases in which HIV-1 RNA was undetectable in the blood and cervix but was detectable in vaginal secretions: one woman had 220 copies/ml and the other 68 copies/ml. These results suggest that pregnant women with undetectable viral loads in blood plasma are still at risk of transmitting the virus vertically during vaginal delivery. Because of this, antiretroviral prophylaxis during vaginal delivery must be administered to HIV-1-infected women and their newborns, regardless of the mother's viral load in plasma. In conclusion, quantification of cervicovaginal levels of HIV-1 may represent a useful tool for assessing the individual risk associated with a vaginal delivery and for guiding decisions about whether a scheduled caesarean should be recommended.
本研究的目的是分析人类免疫缺陷病毒1型RNA(HIV-1 RNA)在HIV-1感染孕妇生殖道中的定量情况,并评估其与血浆病毒载量之间的可能相关性(斯皮尔曼等级相关系数)。在妊娠晚期,从38名妇女中分别采集了38份宫颈、阴道和血液样本,用于定量HIV-1 RNA载量。通过逆转录-聚合酶链反应测定病毒载量。在38份血液样本中的29份(76.3%)、38份宫颈分泌物样本中的6份(15.7%)以及38份阴道分泌物样本中的8份(21%)中可检测到HIV-1 RNA病毒载量。总体而言,血浆中HIV-1 RNA病毒载量与宫颈分泌物样本中的病毒载量之间的相关性为0.51(P<0.001)。然而,当从统计研究中排除三名血浆病毒载量高的患者时,相关性消失(r=0.27)。阴道分泌物中的病毒载量与血液样本中的病毒载量不相关(r=0.26)。有两例血液和宫颈中未检测到HIV-1 RNA,但在阴道分泌物中可检测到:一名妇女的病毒载量为220拷贝/毫升,另一名为68拷贝/毫升。这些结果表明,血浆中病毒载量检测不到的孕妇在阴道分娩期间仍有垂直传播病毒的风险。因此,无论母亲血浆中的病毒载量如何,都必须对HIV-1感染的妇女及其新生儿在阴道分娩期间进行抗逆转录病毒预防。总之,定量检测宫颈阴道水平的HIV-1可能是评估阴道分娩个体风险以及指导是否建议进行择期剖宫产决策的有用工具。